Log In
Print
BCIQ
Print
Print this Print this
 

TZP-301

  Manage Alerts
Collapse Summary General Information
Company Ocera Therapeutics Inc.
DescriptionGhrelin antagonist
Molecular Target Ghrelin
Mechanism of ActionGhrelin antagonist
Therapeutic ModalityMacrocycle
Latest Stage of DevelopmentPreclinical
Standard Indication Metabolic (unspecified)
Indication DetailsTreat metabolic diseases
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today